logo
[breadcrumb_custom]

Tag: PTPI Shares

THMO
News

Petros Pharmaceuticals Inc (PTPI) Stock: From Low to High in 52 Weeks

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Petros Pharmaceuticals Inc’s current trading price is -83.44% away from its 52-week high, while its distance from the 52-week low is 72.26%. The stock’s price range for this time frame has been between $0.92 and $9.54. The trading volume of the company’s shares in the Healthcare reached around 3.8 million for the day, which was evidently higher than the average daily volume of 0.95 million over the last three months. In terms of market performance, Petros Pharmaceuticals Inc had

OPEN Stock
Industry

PTPI’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect?

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The index has shown a price loss of -0.71% this year. Over the last six months, there has been a stronger performance of -56.66%. The price of PTPI fallen by 5.26% during the last 30 days period. For the last 5-days stocks have improved 25.00%. The market performance of Petros Pharmaceuticals Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point

Stock

Petros Pharmaceuticals Inc (PTPI) Stock: A Year of Decreases and Increases

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Petros Pharmaceuticals Inc’s current trading price is -85.48% away from its 52-week high, while its distance from the 52-week low is 51.00%. The stock’s price range for this period has been between $0.92 and $9.54 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 2.5 million for the day, a number notably higher than the average daily volume of 0.42 million over the last three months. The market performance of Petros Pharmaceuticals Inc’s

News

Petros Pharmaceuticals Inc Inc. (PTPI) Price Performance: The Role of Supply and Demand

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The index has shown a price loss of -7.80% this year. Over the last six months, there has been a stronger performance of -62.43%. The price of PTPI leaped by -5.80% during the last 30 days period. For the last 5-days stocks have slided -2.26%. Petros Pharmaceuticals Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $9.54 on 04/20/23, and the lowest price during the same period

Market Activity

Petros Pharmaceuticals, Inc. (PTPI) Stock Surging in Premarket Trading Session

Petros Pharmaceuticals, Inc. (PTPI), a pharmaceutical company, has surged 7.83% in the premarket trading session and consequently is trading at $1.79 at the time of the writing. On Thursday, the stock closed the day at $1.66 after sliding by 9.29% during the regular trading session. The last press release from the company was regarding the launch of studies for STENDRA. PTPI Initiated Self-Selection Studies On Tuesday, PTPI announced that it had initiated the two self-selection studies for its erectile dysfunction (ED) drug STENDRA® (avanafil). The company said that the results of eh study would be part of a comprehensive data package that